Article Versions Notes

Johnson RL, Cummings M, Thangavelu A, Theophilou G, de Jong D, Orsi NM. Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment. Cancers. 2021; 13(24):6231. https://doi.org/10.3390/cancers13246231

Johnson, Racheal Louise, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick de Jong, and Nicolas Michel Orsi. 2021. "Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment" Cancers 13, no. 24: 6231. https://doi.org/10.3390/cancers13246231

Johnson, R. L., Cummings, M., Thangavelu, A., Theophilou, G., de Jong, D., & Orsi, N. M. (2021). Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment. Cancers, 13(24), 6231. https://doi.org/10.3390/cancers13246231